To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MEIS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
288 supporting clones for gene MEIS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_57198812   MEIS1.a 1 to 768 24 to 797   tiling clone,   772/892
(86 %)
19 diff
(97.9 %id)
BI822714 pooled brain, lung, testis MEIS1.a 9 to 768 1 to 766   tiling clone,   764/861
(88 %)
14 diff
(98.4 %id)
CR612956 placenta MEIS1.a 292 to 2934 1 to 2643 exact tiling clone,   2643/2643
(100 %)
0 diff
(100 %id)
AL540672 placenta MEIS1.a 304 to 1228 12 to 936       925/936
(98 %)
6 diff
(99.4 %id)
BX430904 placenta MEIS1.a 1141 to 2038 1 to 896       896/899
(99 %)
12 diff
(98.7 %id)
CV574727 cornea, eye MEIS1.a 1258 to 1868 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CA311376 Human Lung Epithelial cells, lung MEIS1.a 1415 to 2109 713 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
DB223486 trachea MEIS1.a 1508 to 2067 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BG502562 embryonal carcinoma, testis MEIS1.a 1516 to 1983 1 to 468       468/468
(100 %)
0 diff
(100 %id)
AW190836 adenocarcinoma, Pancreas MEIS1.a 1535 to 2033 499 to 1       499/499
(100 %)
1 diff
(99.8 %id)
AW392096 stomach MEIS1.a 1564 to 1913 1 to 350       350/356
(98 %)
9 diff
(97.5 %id)
BG536861 lung MEIS1.a 1571 to 2342 1 to 765       765/839
(91 %)
11 diff
(98.7 %id)
AW452245   MEIS1.a 1591 to 2032 457 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
BG501632 embryonal carcinoma, testis MEIS1.a 1606 to 2352 1 to 751       751/751
(100 %)
6 diff
(99.3 %id)
BF699641 brain, primitive neuroectoderm MEIS1.a 1691 to 2377 1 to 688       688/834
(82 %)
21 diff
(97.5 %id)
AA036998 uterus MEIS1.a 1782 to 1976 195 to 1     Submitted on the opposite strand 195/195
(100 %)
1 diff
(99.5 %id)
AI648608 serous papillary carcinoma, high grade, 2pooled tumors, uterus MEIS1.a 1809 to 2036 228 to 1       228/228
(100 %)
0 diff
(100 %id)
TI_149288109   MEIS1.a 1821 to 2658 921 to 88   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 834/969
(86 %)
8 diff
(99.2 %id)
BM970182 lung MEIS1.a 1914 to 2658 763 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 745/745
(100 %)
1 diff
(99.9 %id)
CN297488 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.a 1934 to 2424 1 to 491       491/495
(99 %)
1 diff
(99.8 %id)
BU618932 Cell Line, Chondrosarcoma MEIS1.a 1946 to 2646 716 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 698/698
(100 %)
3 diff
(99.6 %id)
AL568535 placenta MEIS1.a 1965 to 2824 971 to 113       859/971
(88 %)
0 diff
(100 %id)
BX395037 Neuroblastoma Cot 25-normalized MEIS1.a 2057 to 2601 590 to 10       581/751
(77 %)
0 diff
(100 %id)
AA348951 adrenal gland MEIS1.a 2066 to 2502 1 to 439       439/439
(100 %)
4 diff
(99.1 %id)
BF878474 lung_tumor MEIS1.a 2086 to 2697 9 to 614       606/625
(96 %)
15 diff
(97.6 %id)
R27537 placenta MEIS1.a 2100 to 2461 1 to 371       371/371
(100 %)
13 diff
(96.5 %id)
CB216927 normal endometrium, mid-secretory phase,cycle day 23, uterus MEIS1.a 2118 to 2764 1 to 647       647/647
(100 %)
0 diff
(100 %id)
TI_154015931   MEIS1.a 2140 to 2967 912 to 84   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 829/991
(83 %)
18 diff
(98.2 %id)
AW148847 brain, tumor, 5 pooled (see description) MEIS1.a 2142 to 2651 514 to 4       511/514
(99 %)
0 diff
(100 %id)
AA345085 gall bladder MEIS1.a 2169 to 2516 1 to 349       349/349
(100 %)
4 diff
(98.9 %id)
AA228997   MEIS1.a 2169 to 2362 1 to 192       192/192
(100 %)
4 diff
(98.0 %id)
AA228996   MEIS1.a 2170 to 2552 8 to 390       383/390
(98 %)
6 diff
(98.5 %id)
AI653624 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MEIS1.a 2187 to 2667 483 to 3       481/483
(99 %)
0 diff
(100 %id)
AI871636 carcinoid, lung MEIS1.a 2197 to 2652 464 to 9       456/464
(98 %)
0 diff
(100 %id)
BX351199 Neuroblastoma Cot 25-normalized MEIS1.a 2202 to 2655 451 to 4       448/552
(81 %)
0 diff
(100 %id)
AI802070 carcinoid, lung MEIS1.a 2209 to 2667 463 to 5       459/463
(99 %)
0 diff
(100 %id)
AW243936 serous papillary carcinoma, high grade, 2pooled tumors, uterus MEIS1.a 2223 to 2651 433 to 5       429/433
(99 %)
0 diff
(100 %id)
R15989 whole brain MEIS1.a 2232 to 2651 438 to 5       434/439
(98 %)
0 diff
(100 %id)
AA773264 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MEIS1.a 2232 to 2539 68 to 375       308/375
(82 %)
6 diff
(98.4 %id)
BQ330890 lung_tumor MEIS1.a 2250 to 2712 472 to 8       465/472
(98 %)
0 diff
(100 %id)
N54749 multiple sclerosis lesions MEIS1.a 2255 to 2469 1 to 220   fully sequenced,   220/220
(100 %)
5 diff
(97.8 %id)
AI718785 colon MEIS1.a 2269 to 2646 379 to 1       379/379
(100 %)
8 diff
(97.9 %id)
AI289789 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus MEIS1.a 2273 to 2626 27 to 380     Submitted on the opposite strand 354/380
(93 %)
6 diff
(98.5 %id)
N54742 multiple sclerosis lesions MEIS1.a 2287 to 2491 1 to 205   fully sequenced,   205/205
(100 %)
0 diff
(100 %id)
CB052627 leiomyosarcoma, soft tissue MEIS1.a 2305 to 2967 24 to 685   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 662/685
(96 %)
6 diff
(99.2 %id)
AI342534 lung MEIS1.a 2322 to 2658 347 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 337/337
(100 %)
4 diff
(98.9 %id)
TI_149279842   MEIS1.a 2339 to 2967 690 to 61   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 630/1139
(55 %)
1 diff
(100.0 %id)
CB854199 lung, Primary Lung Epithelial Cells MEIS1.a 2339 to 2967 648 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 630/633
(99 %)
1 diff
(99.9 %id)
AI651256 pooled germ cell tumors MEIS1.a 2342 to 2967 626 to 1       626/626
(100 %)
0 diff
(100 %id)
CA437111 lung, Metastatic Chondrosarcoma MEIS1.a 2343 to 2967 645 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 627/627
(100 %)
2 diff
(99.7 %id)
AW078614 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney MEIS1.a 2375 to 2777 405 to 1       405/405
(100 %)
6 diff
(98.6 %id)
AA230050   MEIS1.a 2376 to 2646 275 to 1       275/275
(100 %)
6 diff
(97.9 %id)
AA230051   MEIS1.a 2376 to 2646 274 to 1       274/274
(100 %)
3 diff
(99.0 %id)
AA230104   MEIS1.a 2376 to 2646 271 to 1       271/271
(100 %)
1 diff
(99.7 %id)
AI521256 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MEIS1.a 2386 to 2665 300 to 22   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 279/279
(100 %)
3 diff
(99.0 %id)
T16586   MEIS1.a 2387 to 2646 260 to 1       260/260
(100 %)
0 diff
(100 %id)
TI_151766032   MEIS1.a 2412 to 2967 104 to 657   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 554/554
(100 %)
6 diff
(99.0 %id)
BF589437 pooled MEIS1.a 2413 to 2968 559 to 4       556/559
(99 %)
0 diff
(100 %id)
AI885947 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MEIS1.a 2431 to 2667 266 to 30       237/266
(89 %)
0 diff
(100 %id)
CK823840 insulinoma, Pancreas MEIS1.a 2432 to 2968 561 to 25     Submitted on the opposite strand 537/561
(95 %)
0 diff
(100 %id)
N45300 multiple sclerosis lesions MEIS1.a 2439 to 2967 534 to 1   fully sequenced,   534/534
(100 %)
8 diff
(98.6 %id)
BF111862 pooled MEIS1.a 2445 to 2967 537 to 13   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 525/525
(100 %)
2 diff
(99.7 %id)
AI480280 pooled MEIS1.a 2446 to 2968 529 to 7       523/529
(98 %)
0 diff
(100 %id)
N45292 multiple sclerosis lesions MEIS1.a 2461 to 2968 499 to 1   fully sequenced,   499/499
(100 %)
12 diff
(97.6 %id)
BM663955 eye, Retina Foveal and Macular MEIS1.a 2465 to 2967 521 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
BQ028112 mixed MEIS1.a 2472 to 2665 205 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 194/202
(96 %)
0 diff
(100 %id)
AI669255 Prostate MEIS1.a 2480 to 2967 488 to 1       488/488
(100 %)
0 diff
(100 %id)
AI978827 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MEIS1.a 2487 to 2967 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AI968410 pooled germ cell tumors MEIS1.a 2487 to 2967 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AW168052 serous papillary carcinoma, high grade, 2pooled tumors, uterus MEIS1.a 2492 to 2967 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
AA600354   MEIS1.a 2493 to 2655 170 to 9       162/170
(95 %)
0 diff
(100 %id)
AI698970 adenocarcinoma, Pancreas MEIS1.a 2493 to 2667 189 to 15       175/189
(92 %)
0 diff
(100 %id)
AI922518 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MEIS1.a 2496 to 2968 480 to 9       472/483
(97 %)
0 diff
(100 %id)
TI_149290946   MEIS1.a 2496 to 2967 612 to 141   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 472/666
(70 %)
13 diff
(98.1 %id)
AI620495 Prostate MEIS1.a 2512 to 2967 480 to 25   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 456/456
(100 %)
1 diff
(99.8 %id)
N52601 multiple sclerosis lesions MEIS1.a 2518 to 2967 470 to 1       470/470
(100 %)
22 diff
(95.4 %id)
AW591523 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MEIS1.a 2532 to 2968 442 to 6       437/442
(98 %)
0 diff
(100 %id)
CN280730 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.a 2533 to 2968 447 to 12     Submitted on the opposite strand 436/447
(97 %)
0 diff
(100 %id)
BE504361 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney MEIS1.a 2534 to 2967 434 to 1       434/434
(100 %)
3 diff
(99.4 %id)
AA679729   MEIS1.a 2535 to 2968 437 to 4       434/437
(99 %)
0 diff
(100 %id)
AI632075 pooled germ cell tumors MEIS1.a 2538 to 2959 430 to 9       422/430
(98 %)
0 diff
(100 %id)
AA001443 eye, retina MEIS1.a 2547 to 2965 421 to 1     Submitted on the opposite strand 421/421
(100 %)
3 diff
(99.3 %id)
AI298326 placenta MEIS1.a 2562 to 2968 414 to 8       407/414
(98 %)
0 diff
(100 %id)
AA780896   MEIS1.a 2579 to 2968 393 to 5       389/393
(98 %)
0 diff
(100 %id)
AA976262 Kidney, kidney tumor MEIS1.a 2579 to 2968 398 to 9       390/398
(97 %)
0 diff
(100 %id)
AW089577 ovary, tumor, 5 pooled (see description) MEIS1.a 2590 to 2649 60 to 1       60/60
(100 %)
0 diff
(100 %id)
AA034934 uterus MEIS1.a 2612 to 2909 1 to 298       298/298
(100 %)
1 diff
(99.7 %id)
AW768847 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney MEIS1.a 2612 to 2967 358 to 1       358/358
(100 %)
2 diff
(99.5 %id)
CN280729 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.a 2621 to 3380 1 to 760   tiling clone,   760/760
(100 %)
0 diff
(100 %id)
AI565367 Kidney MEIS1.a 2633 to 2963 334 to 5       330/338
(97 %)
0 diff
(100 %id)
H90073 melanocyte MEIS1.a 2639 to 2944 309 to 1       309/309
(100 %)
3 diff
(99.1 %id)
AA017297 eye, retina MEIS1.a 2649 to 2966 323 to 3     Submitted on the opposite strand 321/323
(99 %)
0 diff
(100 %id)
AI570965 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MEIS1.a 2655 to 2968 317 to 4       314/317
(99 %)
0 diff
(100 %id)
BF112011 pooled MEIS1.a 2693 to 2974 288 to 7       282/288
(97 %)
0 diff
(100 %id)
H90049 melanocyte MEIS1.a 2700 to 2942 245 to 1       245/255
(96 %)
3 diff
(98.9 %id)
H85988 eye, retina MEIS1.a 2729 to 2965 238 to 1     Submitted on the opposite strand 238/254
(93 %)
1 diff
(99.7 %id)
TI_149313667   MEIS1.a 2763 to 3533 861 to 92   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 770/979
(78 %)
9 diff
(99.1 %id)
AA035599 uterus MEIS1.a 2777 to 2967 191 to 1       191/191
(100 %)
0 diff
(100 %id)
AI886238 serous papillary carcinoma, high grade, 2pooled tumors, uterus MEIS1.a 2789 to 2968 183 to 2       182/183
(99 %)
0 diff
(100 %id)
CB305528 lung, Primary Lung Cystic Fibrosis EpithelialCells MEIS1.a 2843 to 3533 707 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
AI687866 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus MEIS1.a 2850 to 2966 117 to 1       117/117
(100 %)
0 diff
(100 %id)
DA096150 cerebellum MEIS1.b 1 to 445 2 to 446   tiling clone, capped   445/445
(100 %)
0 diff
(100 %id)
DB221543 trachea MEIS1.b 1 to 546 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DB228356 trachea MEIS1.b 1 to 554 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DB287139 uterus MEIS1.b 1 to 548 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
BM457306 embryonal carcinoma, cell line, testis MEIS1.b 12 to 618 1 to 609       609/932
(65 %)
13 diff
(98.7 %id)
DA719110   MEIS1.b 27 to 597 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA479056   MEIS1.b 38 to 610 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA554839   MEIS1.b 45 to 606 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB282067 uterus MEIS1.b 45 to 598 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DB279403 uterus MEIS1.b 47 to 585 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DB280336 uterus MEIS1.b 59 to 597 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
CN346075 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MEIS1.b 80 to 628 13 to 561       549/561
(97 %)
6 diff
(99.0 %id)
CV401991 ovary MEIS1.b 132 to 384 11 to 261       251/261
(96 %)
6 diff
(97.8 %id)
CV401949 ovary MEIS1.b 141 to 401 1 to 260       260/260
(100 %)
6 diff
(97.7 %id)
CV401906 ovary MEIS1.b 143 to 389 256 to 11     Submitted on the opposite strand 246/284
(86 %)
0 diff
(100 %id)
CV402016 ovary MEIS1.b 143 to 401 261 to 1     Submitted on the opposite strand 261/266
(98 %)
10 diff
(96.3 %id)
DA799499 brain MEIS1.b 146 to 696 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DR005735 Prostate MEIS1.b 215 to 928 1 to 712       712/712
(100 %)
7 diff
(99.1 %id)
DA616013   MEIS1.b 218 to 722 2 to 505   tiling clone, capped   504/504
(100 %)
4 diff
(99.3 %id)
DA875446 Prostate MEIS1.b 258 to 832 2 to 572   capped   571/572
(99 %)
5 diff
(99.2 %id)
BM541746 leiomyosarcoma, uterus MEIS1.b 275 to 1108 1 to 831       831/1116
(74 %)
13 diff
(98.9 %id)
NM_002398.2   MEIS1.b 275 to 3454 1 to 3180 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 3180/3180
(100 %)
0 diff
(100 %id)
BM194533 leukopheresis MEIS1.b 426 to 793 1 to 362       362/362
(100 %)
12 diff
(96.7 %id)
BX481682   MEIS1.b 459 to 1075 1 to 612     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 612/612
(100 %)
2 diff
(99.7 %id)
CN346074 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.b 510 to 1177 1 to 668   tiling clone,   668/668
(100 %)
9 diff
(98.7 %id)
AK314949   MEIS1.b 525 to 1904 1 to 1380 D216G     1380/1380
(100 %)
2 diff
(99.9 %id)
DA605605   MEIS1.b 526 to 1037 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
AW511656 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MEIS1.b 611 to 795 1 to 177     Submitted on the opposite strand 177/177
(100 %)
4 diff
(97.8 %id)
AA001444 eye, retina MEIS1.b 642 to 1138 1 to 513     Submitted on the opposite strand 513/513
(100 %)
17 diff
(96.7 %id)
AA017165 eye, retina MEIS1.b 643 to 1081 1 to 444     Submitted on the opposite strand 444/444
(100 %)
7 diff
(98.5 %id)
CK823839 insulinoma, Pancreas MEIS1.b 643 to 1054 20 to 432     Submitted on the opposite strand 413/413
(100 %)
8 diff
(98.1 %id)
CB852923 Human Lung Epithelial cells, lung MEIS1.b 643 to 1282 19 to 657     Submitted on the opposite strand 639/639
(100 %)
1 diff
(99.9 %id)
U85707   MEIS1.b 667 to 3177 1 to 2511 exact tiling clone,   2511/2511
(100 %)
0 diff
(100 %id)
CB215310 normal endometrium, late proliferativephase, cycle day 13, uterus MEIS1.b 672 to 1300 1 to 629       629/629
(100 %)
0 diff
(100 %id)
H86349 eye, retina MEIS1.b 673 to 954 1 to 288     Submitted on the opposite strand 288/302
(95 %)
10 diff
(96.7 %id)
H86356 eye, retina MEIS1.b 696 to 954 1 to 263     Submitted on the opposite strand 263/285
(92 %)
16 diff
(94.4 %id)
BE613169 adenocarcinoma, ovary MEIS1.b 696 to 1362 1 to 673     Submitted on the opposite strand 673/730
(92 %)
11 diff
(98.5 %id)
CN297492 embryonic stem cells, DMSO-treated H9 cellline MEIS1.b 724 to 1239 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
BM510557 insulinoma, Pancreas MEIS1.b 743 to 1097 10 to 364     Submitted on the opposite strand 355/364
(97 %)
13 diff
(96.5 %id)
CN297491 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.b 774 to 1417 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
DA691398   MEIS1.b 793 to 1363 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP313289 mammary gland MEIS1.b 802 to 1383 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA277615 corpus callosum MEIS1.b 803 to 1371 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BX327082 Neuroblastoma Cot 25-normalized MEIS1.b 841 to 1619 1 to 785       785/873
(89 %)
15 diff
(98.3 %id)
AW389821 stomach MEIS1.b 880 to 1334 464 to 12       453/464
(97 %)
0 diff
(100 %id)
BY795133 eye MEIS1.b 953 to 1912 1 to 960       960/960
(100 %)
1 diff
(99.9 %id)
DA480931   MEIS1.b 965 to 1525 4 to 564   capped   561/563
(99 %)
6 diff
(99.0 %id)
DB272407 uterus MEIS1.b 966 to 1513 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA582823 lung MEIS1.b 1018 to 1597 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
FN173547 breast carcinoma MEIS1.b 1027 to 1110 1 to 83       83/83
(100 %)
4 diff
(95.2 %id)
AW999351 breast_normal MEIS1.b 1111 to 1471 381 to 20     Submitted on the opposite strand 362/381
(95 %)
0 diff
(100 %id)
AW999691 breast_normal MEIS1.b 1111 to 1497 395 to 10     Submitted on the opposite strand 386/395
(97 %)
0 diff
(100 %id)
DA292212 hippocampus MEIS1.b 1151 to 1666 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
BP376241 uterus MEIS1.b 1181 to 1761 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA617554   MEIS1.b 1187 to 1768 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA610510   MEIS1.b 1218 to 1766 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BM014915 breast, mammary adenocarcinoma, cell line MEIS1.b 1228 to 1938 1 to 713       713/713
(100 %)
2 diff
(99.8 %id)
TI_59393002   MEIS1.b 1228 to 1938 52 to 764       713/713
(100 %)
2 diff
(99.8 %id)
DA611222   MEIS1.b 1250 to 1716 2 to 469   capped   468/468
(100 %)
1 diff
(99.8 %id)
CV325747 leiomios MEIS1.b 1262 to 1802 25 to 572       548/575
(95 %)
45 diff
(92.2 %id)
DB259162 uterus MEIS1.b 1273 to 1846 2 to 576   capped   575/577
(99 %)
2 diff
(99.7 %id)
DA612845   MEIS1.b 1279 to 1864 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA615115   MEIS1.b 1279 to 1844 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BG109428 Bone, osteosarcoma, cell line MEIS1.b 1293 to 1961 1 to 670       670/671
(99 %)
2 diff
(99.8 %id)
BM716621 eye, fetal eyes MEIS1.b 1320 to 1969 1 to 650       650/650
(100 %)
0 diff
(100 %id)
TI_151798558   MEIS1.b 1320 to 1938 104 to 717       614/655
(93 %)
10 diff
(98.5 %id)
AU129359   MEIS1.b 1328 to 1898 2 to 572   capped   571/808
(70 %)
1 diff
(99.9 %id)
CN297490 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.b 1330 to 1606 1 to 277       277/277
(100 %)
2 diff
(99.3 %id)
W21073 lung MEIS1.b 1335 to 1698 1 to 366       366/372
(98 %)
6 diff
(98.4 %id)
BX112951 lung MEIS1.b 1337 to 2077 1 to 746       746/746
(100 %)
6 diff
(99.2 %id)
DA069309 cerebellum MEIS1.b 1385 to 1957 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AA081754   MEIS1.b 1461 to 1901 1 to 441       441/441
(100 %)
0 diff
(100 %id)
BF916651 uterus_tumor MEIS1.b 1472 to 1659 201 to 14     Submitted on the opposite strand 188/207
(90 %)
1 diff
(99.6 %id)
DA907039   MEIS1.b 1473 to 1933 113 to 573   capped   461/572
(80 %)
6 diff
(99.0 %id)
CD664530   MEIS1.b 1475 to 2076 600 to 1       598/600
(99 %)
9 diff
(98.5 %id)
CN297494 embryonic stem cells, DMSO-treated H9 cellline MEIS1.b 1529 to 2170 1 to 646       646/646
(100 %)
10 diff
(98.5 %id)
BF039005 adenocarcinoma, ovary MEIS1.b 1620 to 2369 14 to 734       721/872
(82 %)
48 diff
(94.5 %id)
DA082894 cerebellum MEIS1.b 1687 to 2260 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BE613007 adenocarcinoma, ovary MEIS1.b 1767 to 2418 646 to 1     Submitted on the opposite strand 646/647
(99 %)
7 diff
(99.0 %id)
R47204   MEIS1.b 1874 to 2008 1 to 134       134/134
(100 %)
4 diff
(97.1 %id)
CA943697 Pancreas, Purified pancreatic islet MEIS1.b 1922 to 2503 582 to 1       582/582
(100 %)
0 diff
(100 %id)
N95243 lung MEIS1.b 2153 to 2520 361 to 1       361/386
(93 %)
7 diff
(98.2 %id)
TI_151717632   MEIS1.b 2366 to 3044 764 to 85       680/764
(89 %)
0 diff
(100 %id)
BX481683   MEIS1.b 2615 to 3145 577 to 47   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 531/531
(100 %)
1 diff
(99.9 %id)
DB366631   MEIS1.b 2887 to 3454 560 to 1   tiling clone,   560/609
(91 %)
17 diff
(97.3 %id)
AL832770 human cervix MEIS1.c -8 to 4594 1 to 4601 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 4601/4601
(100 %)
14 diff
(99.7 %id)
DA718098   MEIS1.c -8 to 430 2 to 440   tiling clone, capped   439/439
(100 %)
2 diff
(99.6 %id)
DA906519   MEIS1.c -8 to 583 2 to 588   tiling clone, capped   587/587
(100 %)
2 diff
(99.7 %id)
DB243813 stomach, tumor tissue MEIS1.c 1 to 550 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
CN346076 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MEIS1.c 158 to 594 27 to 460       434/460
(94 %)
8 diff
(98.3 %id)
CN346077 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MEIS1.c 158 to 621 27 to 487       461/487
(94 %)
9 diff
(98.2 %id)
BM194458 leukopheresis MEIS1.c 158 to 441 1 to 283       283/283
(100 %)
7 diff
(97.6 %id)
BC036511 testis MEIS1.c 165 to 5270 6 to 5108 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 5103/5108
(99 %)
17 diff
(99.7 %id)
DA411838 thalamus MEIS1.c 1591 to 2127 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
DB291586 uterus MEIS1.c 1796 to 2366 2 to 572   tiling clone, capped   571/571
(100 %)
3 diff
(99.5 %id)
BF832205 head_neck MEIS1.c 1929 to 2276 1 to 347       347/347
(100 %)
8 diff
(97.7 %id)
BF832410 head_neck MEIS1.c 1932 to 2350 1 to 416       416/416
(100 %)
11 diff
(97.4 %id)
BF838874 head_neck MEIS1.c 2012 to 2350 86 to 423       338/423
(79 %)
7 diff
(98.4 %id)
GD148486   MEIS1.c 2104 to 2200 97 to 1     Submitted on the opposite strand 97/98
(98 %)
2 diff
(98.0 %id)
DA804043 brain MEIS1.c 2189 to 2728 2 to 541   capped   540/540
(100 %)
4 diff
(99.3 %id)
CV571637 cornea, eye MEIS1.c 2355 to 2936 1 to 582   tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
AA332216 Embryo, 8 weeks MEIS1.c 2646 to 2998 1 to 353       353/361
(97 %)
3 diff
(99.2 %id)
AI376372   MEIS1.c 2713 to 3177 465 to 1       465/465
(100 %)
2 diff
(99.6 %id)
DB261244 uterus MEIS1.c 2831 to 3390 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
DB267382 uterus MEIS1.c 2847 to 3427 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
AI004761   MEIS1.c 2856 to 3181 326 to 1       326/326
(100 %)
1 diff
(99.7 %id)
DA149496 amygdala MEIS1.c 3124 to 3691 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
AL711566 human skeletal muscle MEIS1.c 3174 to 3596 9 to 434       426/434
(98 %)
6 diff
(98.7 %id)
DA349877 substantia nigra MEIS1.c 3227 to 3817 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DB265166 uterus MEIS1.c 3230 to 3820 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DB255308 uterus MEIS1.c 3244 to 3774 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DB258210 uterus MEIS1.c 3250 to 3820 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA405409 thalamus MEIS1.c 3323 to 3871 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DR422102 eye, Pterygium MEIS1.c 3431 to 4132 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
DA548511   MEIS1.c 3587 to 4156 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA363701 subthalamic nucleus MEIS1.c 3639 to 4197 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DB254663 uterus MEIS1.c 3771 to 4345 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA132084 alzheimer cortex MEIS1.c 3784 to 4339 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
T25091   MEIS1.c 3796 to 3907 1 to 113       113/113
(100 %)
3 diff
(97.4 %id)
BP378177 uterus MEIS1.c 3879 to 4461 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA427189 colon MEIS1.c 3911 to 4474 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
AA036954 uterus MEIS1.c 3925 to 4247 1 to 324     Submitted on the opposite strand 324/324
(100 %)
4 diff
(98.8 %id)
AI290624 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MEIS1.c 3925 to 4409 1 to 485     Submitted on the opposite strand 485/489
(99 %)
4 diff
(99.2 %id)
AI337853 uterus MEIS1.c 3925 to 4482 1 to 558     Submitted on the opposite strand 558/558
(100 %)
1 diff
(99.9 %id)
BQ016592 lung, Lung Focal Fibrosis MEIS1.c 3952 to 4645 710 to 18       693/710
(97 %)
0 diff
(100 %id)
DB327090 brain MEIS1.c 5029 to 5579 550 to 1   tiling clone,   550/550
(100 %)
2 diff
(99.7 %id)
DB351651 uterus MEIS1.c 5043 to 5579 537 to 1   tiling clone,   537/537
(100 %)
1 diff
(99.9 %id)
BF057538 fibrotheoma, ovary MEIS1.d 1 to 539 539 to 1   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
AI252832 ovary, papillary serous carcinoma MEIS1.d 201 to 433 248 to 15       234/257
(91 %)
0 diff
(100 %id)
AI685516 Prostate MEIS1.d 237 to 514 278 to 1       278/278
(100 %)
0 diff
(100 %id)
DC389375 Spleen MEIS1.d 434 to 1034 1 to 604       604/604
(100 %)
4 diff
(99.4 %id)
BP372718 umbilical cord MEIS1.d 438 to 1019 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC298707 adrenal gland MEIS1.d 443 to 1014 1 to 572       572/572
(100 %)
0 diff
(100 %id)
AK297109   MEIS1.d 445 to 2357 1 to 1913 S175G tiling clone,   1913/1913
(100 %)
2 diff
(99.9 %id)
DC348800   MEIS1.d 445 to 1010 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC332263 hippocampus MEIS1.d 446 to 988 1 to 543       543/551
(98 %)
0 diff
(100 %id)
DC332270 hippocampus MEIS1.d 446 to 1015 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC360138   MEIS1.d 461 to 970 1 to 510       510/510
(100 %)
0 diff
(100 %id)
DC424361   MEIS1.e 1 to 468 1 to 468   tiling clone,   468/468
(100 %)
1 diff
(99.8 %id)
AK297817 heart MEIS1.e 187 to 1685 1 to 1499   tiling clone,   1499/1499
(100 %)
0 diff
(100 %id)
DC356403 heart MEIS1.e 187 to 957 1 to 770       770/775
(99 %)
4 diff
(99.5 %id)
AA373202 lung MEIS1.e 692 to 859 1 to 168       168/168
(100 %)
0 diff
(100 %id)
DC426101 heart MEIS1.e 1762 to 2271 507 to 1   tiling clone,   507/508
(99 %)
20 diff
(96.1 %id)
BG613379 embryonal carcinoma, testis MEIS1.f 1 to 673 1 to 684   tiling clone,   684/744
(91 %)
37 diff
(95.1 %id)
DA607292   MEIS1.f 247 to 809 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DA906699   MEIS1.g 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
BP325905 prostata MEIS1.g 45 to 623 1 to 578   tiling clone,   578/580
(99 %)
4 diff
(99.4 %id)
DA686564   MEIS1.g 46 to 579 2 to 535   tiling clone, capped   534/535
(99 %)
1 diff
(99.9 %id)
AA604805 adrenal adenoma, adrenal gland MEIS1.h 1 to 325 325 to 1   tiling clone,   325/325
(100 %)
0 diff
(100 %id)
CN297493 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.h 205 to 762 1 to 558 exact tiling clone,   558/558
(100 %)
0 diff
(100 %id)
DA714596   MEIS1.i 1 to 560 2 to 561 P136X tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DB235868 trachea MEIS1.j 1 to 547 2 to 560   tiling clone, capped   559/566
(98 %)
10 diff
(98.3 %id)
AA359548 lung MEIS1.j 37 to 324 1 to 288   tiling clone,   288/288
(100 %)
1 diff
(99.7 %id)
DA594562 lung MEIS1.j 519 to 1084 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA660915   MEIS1.k 1 to 475 2 to 476 exact tiling clone, capped   475/475
(100 %)
1 diff
(99.8 %id)
DA057712 cerebellum MEIS1.l 1 to 578 2 to 580 R19L H20A L21S L22T V23R ... tiling clone, capped   579/579
(100 %)
2 diff
(99.7 %id)
DA618841   MEIS1.m 1 to 581 2 to 584 E66V tiling clone, capped   583/583
(100 %)
3 diff
(99.5 %id)
DB204746 trachea MEIS1.n 1 to 575 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB211781 trachea MEIS1.n 1 to 534 2 to 535   tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
CN297489 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 MEIS1.n 326 to 860 1 to 535 exact tiling clone,   535/535
(100 %)
0 diff
(100 %id)
DC360572   MEIS1.n 380 to 941 1 to 563 R21X H22S T23H V24S T26D ...     563/563
(100 %)
1 diff
(99.9 %id)
DC360795   MEIS1.n 380 to 962 1 to 584 R21X H22S T23H V24S T26D ...     584/584
(100 %)
2 diff
(99.7 %id)
DC360860   MEIS1.n 380 to 969 1 to 592 L7P V8R Q9S E10G E11G ... tiling clone,   592/592
(100 %)
2 diff
(99.7 %id)
DB348544 trachea MEIS1.n 1860 to 2410 553 to 1   tiling clone,   553/553
(100 %)
2 diff
(99.7 %id)
CK903117 Pancreas, Purified pancreatic islet MEIS1.o 1 to 573 1 to 573 exact tiling clone, Submitted on the opposite strand 573/573
(100 %)
0 diff
(100 %id)
CA867974 Pancreas, Purified pancreatic islet MEIS1.o 30 to 542 1 to 513       513/513
(100 %)
0 diff
(100 %id)
DB192349 ovary, tumor tissue MEIS1.p 1 to 546 2 to 547 exact tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
BP376045 uterus MEIS1.q 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BX484904   MEIS1.r-u 1 to 503 1 to 503 E14* tiling clone, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 503/503
(100 %)
3 diff
(99.5 %id)
DA571971 whole embryo, mainly body MEIS1.r-u 1231 to 2006 2 to 772   tiling clone, capped   771/776
(99 %)
10 diff
(98.8 %id)
CA393350 eye, RPE/choroid MEIS1.r-u 2438 to 2961 1 to 525   tiling clone,   525/525
(100 %)
1 diff
(99.9 %id)
BX092126 multiple sclerosis lesions MEIS1.r-u 2531 to 3150 1 to 621   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 621/621
(100 %)
4 diff
(99.4 %id)
AF088018   MEIS1.r-u 2531 to 3160 631 to 1   tiling clone, Submitted on the opposite strand 631/631
(100 %)
2 diff
(99.7 %id)
N50458 multiple sclerosis lesions MEIS1.r-u 2576 to 2965 1 to 399       399/450
(88 %)
55 diff
(87.8 %id)
DB358909 whole embryo, mainly body MEIS1.r-u 2582 to 3150 572 to 1       572/572
(100 %)
27 diff
(95.3 %id)
BX484905   MEIS1.r-u 2602 to 3150 570 to 21   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 550/550
(100 %)
2 diff
(99.7 %id)
AA513171 Ewing's sarcoma MEIS1.r-u 2666 to 3027 1 to 363   tiling clone,   363/363
(100 %)
3 diff
(99.2 %id)
N50406 multiple sclerosis lesions MEIS1.r-u 2834 to 3151 320 to 1       320/322
(99 %)
6 diff
(98.2 %id)
AA593515 Prostate, prostatic intraepithelial neoplasia - highgrade MEIS1.r-u 2916 to 3158 1 to 243       243/291
(83 %)
9 diff
(97.0 %id)
AA593254 Prostate, prostatic intraepithelial neoplasia - highgrade MEIS1.r-u 2918 to 3158 1 to 242       242/291
(83 %)
7 diff
(97.6 %id)
BF222036 Prostate MEIS1.r-u 2944 to 3150 207 to 1       207/208
(99 %)
1 diff
(99.6 %id)
BF346640 anaplastic oligodendroglioma with 1p/19qloss, brain MEIS1.r-u 3112 to 3859 1 to 761   tiling clone,   761/872
(87 %)
23 diff
(97.4 %id)
DA475717   MEIS1.s 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AI203963 lung MEIS1.t 1 to 381 33 to 413 D6N D7N A54V S66F tiling clone, Submitted on the opposite strand 381/381
(100 %)
12 diff
(96.9 %id)
DA901595   MEIS1.u 1 to 525 2 to 526 exact tiling clone, capped   525/525
(100 %)
0 diff
(100 %id)
DB278877 uterus MEIS1.va-u 1 to 546 2 to 547 exact tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
DA867577 Prostate MEIS1.va-u 225 to 744 2 to 522   tiling clone, capped   521/521
(100 %)
1 diff
(99.9 %id)
DA933435 Spleen MEIS1.vb 1 to 548 2 to 550 exact tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
DW429796 Liver MEIS1.vc-u 1 to 385 12 to 396 exact tiling clone,   385/396
(97 %)
6 diff
(98.5 %id)
BM148507 leukopheresis MEIS1.vc-u 206 to 497 350 to 58   AAA   293/293
(100 %)
26 diff
(91.2 %id)
AA837750 ovary MEIS1.vc-u 235 to 518 9 to 292   tiling clone,   284/292
(97 %)
6 diff
(98.0 %id)
BC043503 Uterus, leiomyosarcoma Gene MEIS1, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
AK098174 trachea Gene MEIS1, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AL701321 human skeletal muscle Gene MEIS1, variant not shown         Suspected internal deletion, this clone was ignored    
DB268670 uterus Gene MEIS1, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB299212 cerebellum Gene MEIS1, variant not shown         This clone was ignored    
DA102123 cerebellum Gene MEIS1, variant not shown       capped This clone was ignored    
H14339 whole brain Gene MEIS1, variant not shown         Submitted on the opposite strand    
H14388 whole brain Gene MEIS1, variant not shown         Submitted on the opposite strand    
AI400850 Prostate Gene MEIS1, variant not shown         Suspected internal deletion, this clone was ignored    
CO400849 Chondrosarcoma Lung Metastasis cell lines, lung Gene MEIS1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t, .u, .va-u, .vb, .vc-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI